Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor
Authors
Keywords
SARS-CoV-2, FRET, Biosensor, ACE2, Live-cell imaging
Journal
SENSORS AND ACTUATORS B-CHEMICAL
Volume 334, Issue -, Pages 129663
Publisher
Elsevier BV
Online
2021-02-17
DOI
10.1016/j.snb.2021.129663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
- (2020) Chunyan Yi et al. Cellular & Molecular Immunology
- Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea
- (2020) Di Ma et al. EYE
- Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
- (2020) Priyanka Pahan et al. Journal of Neuroimmune Pharmacology
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
- (2020) Houcemeddine Othman et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
- (2020) Jinsung Yang et al. Nature Communications
- ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis
- (2016) Ana Cristina Simões e Silva et al. PHARMACOLOGICAL RESEARCH
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
- (2014) Fan Jiang et al. Nature Reviews Cardiology
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- ACE2, a promising therapeutic target for pulmonary hypertension
- (2011) Vinayak Shenoy et al. CURRENT OPINION IN PHARMACOLOGY
- Angiotensin-converting enzyme 2 in the brain: properties and future directions
- (2008) Huijing Xia et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More